Association between cigarette smoking and Parkinson’s disease: A meta-analysis

Allam, 2004, Parkinson’s disease protects against smoking?, Behavioural Neurology, 15, 65, 10.1155/2004/516302

Allam, 2004, Smoking and Parkinson’s disease: systematic review of prospective studies, Movement Disoroder, 19, 614, 10.1002/mds.20029

Berlin, 2012, A selective reversible monoamine oxidase B inhibitor in smoking cessation: effects on its own and in association with transdermal nicotine patch, Psychopharmacology (Berl), 223, 89, 10.1007/s00213-012-2692-2

Carradori, 2014, Selective MAO-B inhibitors: a lesson from natural products, Molecular Diversity, 18, 219, 10.1007/s11030-013-9490-6

Castagnoli, 2004, Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson’s disease and neuroprotection; are there links?, Neurotoxicology, 25, 279, 10.1016/S0161-813X(03)00107-4

Davie, 2008, A review of Parkinson’s disease, British Medical Bulletin, 86, 109, 10.1093/bmb/ldn013

De Lau, 2006, Epidemiology of Parkinson’s disease, The Lancet. Neurolology, 5, 525, 10.1016/S1474-4422(06)70471-9

Derkinderen, 2014, Gut feelings about smoking and coffee in Parkinson’s disease, Movement Disorder, 29, 976, 10.1002/mds.25882

Hernán, 2002, A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson’s disease, Annals of Neurology, 52, 276, 10.1002/ana.10277

Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 27, 557, 10.1136/bmj.327.7414.557

Hong, 2009, Smoking and Parkinson’s disease: does nicotine affect α-synuclein fibrillation?, Biochimica et Biophysica Acta, 1794, 282, 10.1016/j.bbapap.2008.09.026

Huxley, 2011, Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies, Lancet, 378, 1297, 10.1016/S0140-6736(11)60781-2

Lees, 2009, Parkinson’s disease, Lancet, 373, 2055, 10.1016/S0140-6736(09)60492-X

Li, 2012, A meta-analysis of tea drinking and risk of Parkinson’s disease, Scientific World Journal, 2012, 923464, 10.1100/2012/923464

Maele-Fabry, 2012, Occupational exposure to pesticides and Parkinson’s disease: a systematic review and meta-analysis of cohort studies, Environment International, 46, 30, 10.1016/j.envint.2012.05.004

Mudo, 2007, Nicotinic receptor agonists as neuroprotective neurotrophic drugs: progress in molecular mechanisms, Journal of Neural Transmission, 114, 135, 10.1007/s00702-006-0561-z

Noyce, 2012, Meta-analysis of early nonmotor features and risk factors for Parkinson disease, Annals of Neurology, 72, 893, 10.1002/ana.23687

Quik, 2004, Smoking, nicotine and Parkinson’s disease, Trends in Neurosciences, 27, 561, 10.1016/j.tins.2004.06.008

Quik, 2009, Multiple roles for nicotine in Parkinson’s disease, Biochemical Pharmacology, 78, 677, 10.1016/j.bcp.2009.05.003

Ritz, 2007, Pooled analysis of tobacco use and risk of Parkinson disease, Archieves of Neurology, 64, 990, 10.1001/archneur.64.7.990

Rodgman, 2013

Schapira, 2009, Neurobiology and treatment of Parkinson’s disease, Trends in Pharmacological Sciences, 30, 41, 10.1016/j.tips.2008.10.005

Schapira, 2011, Monoamine oxidase B inhibitors for the treatment of Parkinson’s disease: a review of symptomatic and potential disease-modifying effects, CNS Drugs, 25, 1061, 10.2165/11596310-000000000-00000

Shen, 2013, Low uric acid levels in patients with Parkinson's disease: evidence from meta-analysis, BMJ Open, 3, e003620, 10.1136/bmjopen-2013-003620

Stroup, 2000, Meta-analysis of observational studies in epidemiology. A proposal for reporting, JAMA, 283, 2008, 10.1001/jama.283.15.2008

Tanner, 2002, Smoking and Parkinson’s disease in twins, Neurology, 58, 581, 10.1212/WNL.58.4.581

WHO, 2008

Wirdefeldt, 2011, Epidemiology and etiology of Parkinson’s disease: a review of the evidence, European Journal of Epidemiology, 26, S1, 10.1007/s10654-011-9581-6

Zhang, 1998, What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes, JAMA, 280, 1690, 10.1001/jama.280.19.1690